داروسازی‌ اکسیر

دلر | Stocks - Tehran Stock Exchange (TSE)

داروهای شیمیایی و گیاهی

Sector:

Market Type:

Status:

Last Price: 28,620 1.85

Close Price: 28,360

	2026/06/28 Fiscal Year 2026/03/2012 Month	2025/05/31 Fiscal Year 2025/03/2012 Month	2024/05/29 Fiscal Year 2024/03/1912 Month
Net Profit to Sales	26.75	24.59	26.55
Gross Profit to Sales	34.51	29.85	32.58
Operating Margin	41.97	39.64	41.8
Gross Profit to Sales	45.11	42.65	44.09
Net Profit to Gross Profit	59.31	57.65	60.23
Return on Assets (ROA)	23.44	17.87	22.58
Return on Capital (%)	168.15	457.36	444.99
Return on Equity (ROE)	52.44	51.59	75.2
Working Capital Return	70.14	75.35	91.71
Fixed Asset Return	189.66	153.46	382.53
Loan Benefit Assessment	2.24	2.89	3.33
Current Ratio	1.62	1.37	1.36
Quick Ratio	1.27	1.04	1.01
Liquidity Ratio	0.03	0.03	0.07
Net Working Capital	22,095,236	13,656,795	10,917,661
Current Assets Ratio	0.87	0.88	0.94
Inventory Turnover	142.79	175.13	173.33
Receivables Collection Period	259.59	296.38	224.04
Inventory to Working Capital	0.57	0.9	0.98
Working Capital Turnover	2.62	3.06	3.45
Fixed Asset Turnover	7.09	6.24	14.41
Total Asset Turnover	0.88	0.73	0.85
Debt Ratio	0.55	0.65	0.7
Debt to Equity	1.24	1.89	2.33
Long-Term Debt to Equity	0.03	0.03	0.03
Current Debt to Equity	1.21	1.86	2.31
Equity Ratio	44.7	34.65	30.02
Debt Coverage Ratio	9.48	12.52	7.68

At a Glance